BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15193138)

  • 1. Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability.
    Usach I; Melis V; Peris JE
    J Int AIDS Soc; 2013 Sep; 16(1):1-14. PubMed ID: 24008177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturally Occurring Calanolides: Occurrence, Biosynthesis, and Pharmacological Properties Including Therapeutic Potential.
    Nahar L; Talukdar AD; Nath D; Nath S; Mehan A; Ismail FMD; Sarker SD
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33126458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivatives.
    Sakakibara N; Balboni G; Congiu C; Onnis V; Demizu Y; Misawa T; Kurihara M; Kato Y; Maruyama T; Toyama M; Okamoto M; Baba M
    Antivir Chem Chemother; 2015 Apr; 24(2):62-71. PubMed ID: 26514833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HEPT Analogue WPR-6 Is Active against a Broad Spectrum of Nonnucleoside Reverse Transcriptase Drug-Resistant HIV-1 Strains of Different Serotypes.
    Xu W; Zhao J; Sun J; Yin Q; Wang Y; Jiao Y; Liu J; Jiang S; Shao Y; Wang X; Ma L
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4882-8. PubMed ID: 26055365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical property-driven optimization of diarylaniline compounds as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Liu N; Qin B; Sun LQ; Yu F; Lu L; Jiang S; Lee KH; Xie L
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3719-23. PubMed ID: 25042339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development and validation of an UHPLC-MS/MS method for the rapid quantification of the antiretroviral agent dapivirine in human plasma.
    Seserko LA; Emory JF; Hendrix CW; Marzinke MA
    Bioanalysis; 2013 Nov; 5(22):2771-83. PubMed ID: 24256358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of 1-[(2-benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils as potent HIV-1 non-nucleoside reverse transcriptase inhibitors with an improved drug resistance profile.
    Wang X; Zhang J; Huang Y; Wang R; Zhang L; Qiao K; Li L; Liu C; Ouyang Y; Xu W; Zhang Z; Zhang L; Shao Y; Jiang S; Ma L; Liu J
    J Med Chem; 2012 Mar; 55(5):2242-50. PubMed ID: 22283377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentrations of dapivirine in the rhesus macaque and rabbit following once daily intravaginal administration of a gel formulation of [14C]dapivirine for 7 days.
    Nuttall JP; Thake DC; Lewis MG; Ferkany JW; Romano JW; Mitchnick MA
    Antimicrob Agents Chemother; 2008 Mar; 52(3):909-14. PubMed ID: 18086845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
    Balzarini J
    Curr Top Med Chem; 2004; 4(9):921-44. PubMed ID: 15134549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the development of next generation non-nucleoside reverse transcriptase inhibitors.
    Tarby CM
    Curr Top Med Chem; 2004; 4(10):1045-57. PubMed ID: 15193138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections.
    Pauwels R
    Curr Opin Pharmacol; 2004 Oct; 4(5):437-46. PubMed ID: 15351347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Boone LR
    Curr Opin Investig Drugs; 2006 Feb; 7(2):128-35. PubMed ID: 16499282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress in HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)].
    Zhou T; Xie L
    Yao Xue Xue Bao; 2004 Aug; 39(8):666-72. PubMed ID: 15563074
    [No Abstract]   [Full Text] [Related]  

  • 14. The emerging roles of non-nucleoside reverse transcriptase inhibitors in antiretroviral therapy.
    Moyle G
    Drugs; 2001; 61(1):19-26. PubMed ID: 11217868
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.